{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T02:25:49Z","timestamp":1789784749769,"version":"4.0.1"},"reference-count":52,"publisher":"MJS Publishing, Medical Journals Sweden AB","license":[{"start":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T00:00:00Z","timestamp":1747612800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Derm Venereol"],"abstract":"<jats:p>Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease characterized by recurring dermal abscesses and cutaneous fistulas of intertriginous skin regions, significantly impacting patients\u2019 quality of life. While HS has been associated with various comorbidities such as metabolic and chronic inflammatory diseases, many systemic effects of this systemic disease remain to be investigated. In this study, 2 cohorts of patients with and without HS were created \u2013 matched for sex, age, and nicotine dependence \u2013 each comprising 28,986 patients, using the real-world database TriNetX, to investigate the association of ocular diseases and HS. Not only an increased risk of disorders of refraction and accommodation in HS patients (OR 3.466; 95% CI 3.100, 3.876), but also a higher risk of ocular diseases, including disorders of the lacrimal system, was demonstrated when compared with the control cohort (OR 3.523; 95%CI 2.912, 4.263). Although previous studies have suggested an increased risk of ocular comorbidities in HS patients, ocular history is not routinely queried during visits. Here, the need for further exploration of the association of ocular diseases and HS and for incorporating this into clinical practice is emphasized.<\/jats:p>","DOI":"10.2340\/actadv.v105.42716","type":"journal-article","created":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T04:18:33Z","timestamp":1747714713000},"page":"adv42716","source":"Crossref","is-referenced-by-count":4,"title":["Hidradenitis Suppurativa and Ocular Diseases: Real-world Evidence of 57,972 Patients"],"prefix":"10.2340","volume":"105","author":[{"given":"Jennifer","family":"Von Stebut-Marx","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Preissner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylke","family":"Schneider-Burrus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saskia","family":"Preissner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1183","published-online":{"date-parts":[[2025,5,19]]},"reference":[{"key":"112093","doi-asserted-by":"crossref","unstructured":"Saunte DML, Jemec GBE. Hidradenitis suppurativa: advances in diagnosis and treatment. JAMA 2017; 318: 2019\u20132032.","DOI":"10.1001\/jama.2017.16691"},{"key":"112094","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1001\/jama.2017.16691","DOI":"10.1001\/jama.2017.16691"},{"key":"112095","doi-asserted-by":"crossref","unstructured":"Sabat R, Jemec GBE, Matusiak L, Kimball AB, Prens E, Wolk K. Hidradenitis suppurativa. Nat Rev Dis Primers 2020; 6: 18.","DOI":"10.1038\/s41572-020-0149-1"},{"key":"112096","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1038\/s41572-020-0149-1","DOI":"10.1038\/s41572-020-0149-1"},{"key":"112097","doi-asserted-by":"crossref","unstructured":"Matusiak L, Bieniek A, Szepietowski JC. Hidradenitis suppurativa markedly decreases quality of life and professional activity. J Am Acad Dermatol 2010; 62: 706\u2013708, 708 e701.","DOI":"10.1016\/j.jaad.2009.09.021"},{"key":"112098","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.jaad.2009.09.021","DOI":"10.1016\/j.jaad.2009.09.021"},{"key":"112099","doi-asserted-by":"crossref","unstructured":"Schneider-Burrus S, Tsaousi A, Barbus S, Huss-Marp J, Witte K, Wolk K, et al. Features associated with quality of life impairment in hidradenitis suppurativa patients. Front Med (Lausanne) 2021; 8: 676241.","DOI":"10.3389\/fmed.2021.676241"},{"key":"112100","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.3389\/fmed.2021.676241","DOI":"10.3389\/fmed.2021.676241"},{"key":"112101","doi-asserted-by":"crossref","unstructured":"Hanna N, Silverberg OM, Reaume M, Gladman D, Davis MDP, Piguet V, et al. Incidence, prevalence, and predictors of inflammatory arthritis in patients with hidradenitis suppurativa: a systematic review and meta-analysis. Int J Dermatol 2022; 61: 1069\u20131079.","DOI":"10.1111\/ijd.15860"},{"key":"112102","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/ijd.15860","DOI":"10.1111\/ijd.15860"},{"key":"112103","doi-asserted-by":"crossref","unstructured":"Sabat R, Chanwangpong A, Schneider-Burrus S, Metternich D, Kokolakis G, Kurek A, et al. Increased prevalence of metabolic syndrome in patients with acne inversa. PLoS One 2012; 7: e31810.","DOI":"10.1371\/journal.pone.0031810"},{"key":"112104","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1371\/journal.pone.0031810","DOI":"10.1371\/journal.pone.0031810"},{"key":"112105","doi-asserted-by":"crossref","unstructured":"Egeberg A, Jemec GBE, Kimball AB, Bachelez H, Gislason GH, Thyssen JP, et al. Prevalence and risk of inflammatory bowel disease in patients with hidradenitis suppurativa. J Invest Dermatol 2017; 137: 1060\u20131064.","DOI":"10.1016\/j.jid.2016.11.040"},{"key":"112106","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.jid.2016.11.040","DOI":"10.1016\/j.jid.2016.11.040"},{"key":"112107","doi-asserted-by":"crossref","unstructured":"Shlyankevich J, Chen AJ, Kim GE, Kimball AB. Hidradenitis suppurativa is a systemic disease with substantial comorbidity burden: a chart-verified case-control analysis. J Am Acad Dermatol 2014; 71: 1144\u20131150.","DOI":"10.1016\/j.jaad.2014.09.012"},{"key":"112108","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.jaad.2014.09.012","DOI":"10.1016\/j.jaad.2014.09.012"},{"key":"112109","doi-asserted-by":"crossref","unstructured":"Motlagh M, Fortenbach C, Maibach HI, Modjtahedi BS. Identifying and treating ocular manifestations in psoriasis. Am J Clin Dermatol 2022; 23: 51\u201360.","DOI":"10.1007\/s40257-021-00648-x"},{"key":"112110","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1007\/s40257-021-00648-x","DOI":"10.1007\/s40257-021-00648-x"},{"key":"112111","doi-asserted-by":"crossref","unstructured":"Conic RRZ, Fabbrocini G, Marasca C, Bragazzi NL, Watad A, Adawi M, et al. Burden of ocular comorbidities in patients with hidradenitis suppurativa. JAMA Dermatol 2021; 157: 226\u2013227.","DOI":"10.1001\/jamadermatol.2020.5087"},{"key":"112112","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1001\/jamadermatol.2020.5087","DOI":"10.1001\/jamadermatol.2020.5087"},{"key":"112113","doi-asserted-by":"crossref","unstructured":"Liu F, Panagiotakos D. Real-world data: a brief review of the methods, applications, challenges and opportunities. BMC Med Res Methodol 2022; 22: 287.","DOI":"10.1186\/s12874-022-01768-6"},{"key":"112114","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1186\/s12874-022-01768-6","DOI":"10.1186\/s12874-022-01768-6"},{"key":"112115","doi-asserted-by":"crossref","unstructured":"Palchuk MB, London JW, Perez-Rey D, Drebert ZJ, Winer-Jones JP, Thompson CN, et al. A global federated real-world data and analytics platform for research. JAMIA Open 2023; 6: ooad035.","DOI":"10.1093\/jamiaopen\/ooad035"},{"key":"112116","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1093\/jamiaopen\/ooad035","DOI":"10.1093\/jamiaopen\/ooad035"},{"key":"112117","doi-asserted-by":"crossref","unstructured":"Pinazo-Duran MD, Zanon-Moreno V, Garcia-Medina JJ, Arevalo JF, Gallego-Pinazo R, Nucci C. Eclectic ocular comorbidities and systemic diseases with eye involvement: a review. Biomed Res Int 2016; 2016: 6215745.","DOI":"10.1155\/2016\/6215745"},{"key":"112118","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1155\/2016\/6215745","DOI":"10.1155\/2016\/6215745"},{"key":"112119","doi-asserted-by":"crossref","unstructured":"Gau SY, Liu PY, Chen SN, Chiu TM, Tsai RY, Chang HC, et al. Risk of keratitis and keratopathy in hidradenitis suppurativa patients: a global federated health network analysis. In Vivo 2024; 38: 1375\u20131383.","DOI":"10.21873\/invivo.13578"},{"key":"112120","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.21873\/invivo.13578","DOI":"10.21873\/invivo.13578"},{"key":"112121","doi-asserted-by":"crossref","unstructured":"Schargus M, Langhorst CA, Joachim S, Frings A, Krause K, Reifenberger J, et al. Hidradenitis suppurativa is associated with symptoms of keratoconjunctivitis sicca. Curr Eye Res 2021; 46: 23\u201330.","DOI":"10.1080\/02713683.2020.1775259"},{"key":"112122","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1080\/02713683.2020.1775259","DOI":"10.1080\/02713683.2020.1775259"},{"key":"112123","doi-asserted-by":"crossref","unstructured":"Saygin D, Syed AU, Lowder CY, Srivastava S, Maya JJ, Hajj-Ali RA. Characteristics of inflammatory eye disease associated with hidradenitis suppurativa. Eur J Rheumatol 2018; 5: 165\u2013168.","DOI":"10.5152\/eurjrheum.2018.17163"},{"key":"112124","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.5152\/eurjrheum.2018.17163","DOI":"10.5152\/eurjrheum.2018.17163"},{"key":"112125","doi-asserted-by":"crossref","unstructured":"Li CP, Lin CY, Lu HY, Chen SN, Tsai RY, Chang HC, et al. Patients with hidradenitis suppurativa are associated with risk of new-onset glaucoma: a propensity-score-matched cohort study. Int J Med Sci 2024; 21: 2208\u20132214.","DOI":"10.7150\/ijms.95395"},{"key":"112126","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.7150\/ijms.95395","DOI":"10.7150\/ijms.95395"},{"key":"112127","doi-asserted-by":"crossref","unstructured":"Cheng CY. Risk of incident cataract in patients with psoriasis: a population-based cohort study. J Dermatol 2022; 49: 359\u2013367.","DOI":"10.1111\/1346-8138.16261"},{"key":"112128","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/1346-8138.16261","DOI":"10.1111\/1346-8138.16261"},{"key":"112129","doi-asserted-by":"crossref","unstructured":"Akcam HT, Karagun E, Iritas I, Eyup Y. Keratoconus could be associated with psoriasis: novel findings from a comparative study. Cornea 2019; 38: 1524\u20131530.","DOI":"10.1097\/ICO.0000000000002161"},{"key":"112130","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1097\/ICO.0000000000002161","DOI":"10.1097\/ICO.0000000000002161"},{"key":"112131","doi-asserted-by":"crossref","unstructured":"Manfredini M, Ragusa E, Gibertini M, Bigi L, Ferrari B, Lasagni C, et al. Retinal microvascular alterations in hidradenitis suppurativa patients: a pilot study using optical coherence tomography angiography. J Clin Med 2024; 13: 1464.","DOI":"10.3390\/jcm13051464"},{"key":"112132","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.3390\/jcm13051464","DOI":"10.3390\/jcm13051464"},{"key":"112133","doi-asserted-by":"crossref","unstructured":"Demirci G, Erdur SK, Aydin R, Balevi A, Eliacik M, Ozsutcu M, et al. Tear osmolarity and ocular surface parameters in patients with psoriasis. Arq Bras Oftalmol 2017; 80: 1\u20133.","DOI":"10.5935\/0004-2749.20170002"},{"key":"112134","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.5935\/0004-2749.20170002","DOI":"10.5935\/0004-2749.20170002"},{"key":"112135","doi-asserted-by":"crossref","unstructured":"Zengin N, Tol H, Balevi S, Gunduz K, Okudan S, Endogru H. Tear film and meibomian gland functions in psoriasis. Acta Ophthalmol Scand 1996; 74: 358\u2013360.","DOI":"10.1111\/j.1600-0420.1996.tb00708.x"},{"key":"112136","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/j.1600-0420.1996.tb00708.x","DOI":"10.1111\/j.1600-0420.1996.tb00708.x"},{"key":"112137","doi-asserted-by":"crossref","unstructured":"Kudasiewicz-Kardaszewska A, Grant-Kels JM, Grzybowski A. Meibomian gland dysfunction and blepharitis: a common and still unsolved ophthalmic problem. Clin Dermatol 2023; 41: 491\u2013502.","DOI":"10.1016\/j.clindermatol.2023.08.005"},{"key":"112138","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.clindermatol.2023.08.005","DOI":"10.1016\/j.clindermatol.2023.08.005"},{"key":"112139","doi-asserted-by":"crossref","unstructured":"Goel R, Saini S, Golhait P, Shah S. Association of primary chronic dacryocystitis and meibomian gland dysfunction. Indian J Ophthalmol 2024; 72: 185\u2013189.","DOI":"10.4103\/IJO.IJO_1449_23"},{"key":"112140","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.4103\/IJO.IJO_1449_23","DOI":"10.4103\/IJO.IJO_1449_23"},{"key":"112141","doi-asserted-by":"crossref","unstructured":"Galor A, Lee DJ. Effects of smoking on ocular health. Curr Opin Ophthalmol 2011; 22: 477\u2013482.","DOI":"10.1097\/ICU.0b013e32834bbe7a"},{"key":"112142","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1097\/ICU.0b013e32834bbe7a","DOI":"10.1097\/ICU.0b013e32834bbe7a"},{"key":"112143","doi-asserted-by":"crossref","unstructured":"Konig A, Lehmann C, Rompel R, Happle R. Cigarette smoking as a triggering factor of hidradenitis suppurativa. Dermatology 1999; 198: 261\u2013264.","DOI":"10.1159\/000018126"},{"key":"112144","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1159\/000018126","DOI":"10.1159\/000018126"}],"container-title":["Acta Dermato-Venereologica"],"original-title":[],"link":[{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/42716\/50168","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/42716\/50169","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/42716\/50168","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T08:37:27Z","timestamp":1747730247000},"score":1,"resource":{"primary":{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/view\/42716"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,19]]},"references-count":52,"URL":"https:\/\/doi.org\/10.2340\/actadv.v105.42716","relation":{},"ISSN":["1651-2057","0001-5555"],"issn-type":[{"value":"1651-2057","type":"electronic"},{"value":"0001-5555","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,19]]}}}